ASP-9801

N/A

Report date: 2022/01/17 12:14:22

Base Information

Drug NameASP-9801
Drug Alias NameASP-9801
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionCell death stimulantsImmunostimulantsInterleukin-12 receptor stimulants +[4] 
TargetsInterleukin-12 receptorInterleukin-7 receptor subunit alpha
Therapy Area/IndicationsSolid tumoursNeoplasm MetastasisNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAstellas Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesAstellas Pharma Global Development Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursNeoplasm Metastasis
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A